Corporate Profile
Cleveland BioLabs, Inc. (Nasdaq:CBLI) is a drug discovery and development company leveraging its proprietary mechanistic discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. CBLI has strategic partnerships with the Cleveland Clinic, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Radiobiology Research Institute. More...
Recent News
More > >
Featured Report
Presentation Materials
